Avid Bioservices Inc (CDMO)

[bfiest]

More researched facts and projections:

The global CDMO (Contract Development and Manufacturing Organizations) Industry market is projected to reach a size of 278 billion dollars by 2024.

The CDMO industry is expected to grow at a CAGR (Compound Annual Growth Rate) of 12.4% from 2020 to 2026.

The market for CDMOs is expanding because of a number of developments, including the expansion of small and mid-sized pharma and biotech firms, the trend toward personalized medicine, and the rising need for biologics.

The Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market revenue in the United States was valued at USD 54.21 billion in 2023.

While China and India have established themselves as significant providers of API manufacturing services, the United States continues to be the main outsourcing hub for pharmaceutical companies.

The Biologics CDMO Market size is expected to grow from USD 15.83 billion in 2023 to USD 33.95 billion by 2030, at a CAGR of 11.51% during the forecast period (2023-2028).



Bottom line: the market, albeit currently tougher, is poised to come back soon and offers viable opportunities for Avid’s growth in my opinion.